Reaching Women with Instructions on Misoprostol Use in a Latin American Country

References

• D Wulf, S Singh. An Overview of Clandestine Abortion in Latin America. 1996; Alan Guttmacher Institute: New York. At: <www.guttmacher.org/pubs/ib12.html. >. Accessed 18 May 2005.
   Google Scholar
• World Health Organization. Unsafe abortion: global and regional estimates of the incidence of unsafe abortion and associated mortality in 2000. 4th ed, 2004; WHO: Geneva. At: <www.who.int/reproductive-health/unsafe_abortion/. >. Accessed 12 August 2005.
   Google Scholar
• YS Chong, LL Su, S Arulkumaran. Misoprostol: a quarter century of use, abuse, and creative misuse. Obstetrical and Gynecological Survey. 59(2): 2004; 128–140.
   PubMed Web of Science ®Google Scholar
• AU Lokugamage, H El Refaey, CH Rodeck. Misoprostol and pregnancy: ever-increasing indications of effective usage. Current Opinion in Obstetrics and Gynecology. 15(6): 2003; 513–518.
   Web of Science ®Google Scholar
• M Burns. Misoprostol use in obstetrics and gynecology. Outlook. 21(4): 2005; 1–8.
   Google Scholar
• S Clark, J Blum, K Blanchard. Misoprostol use in obstetrics and gynecology in Brazil, Jamaica, and the United States. International Journal of Gynecology and Obstetrics. 76(1): 2002; 65–74.
   Web of Science ®Google Scholar
• PW Ashok, GC Penney, GMM Flett. An effective regimen for early medical abortion: a report of 2000 consecutive cases. Human Reproduction. 13(10): 1998; 2962–2965.
   Web of Science ®Google Scholar
• EA Schaff, SL Fielding, C Westhoff. Vaginal misoprostol administered 1, 2, or 3 days after mifepristone for early medical abortion: a randomized trial. Journal of the American Medical Association. 284: 2000; 1948–1953.
   PubMed Web of Science ®Google Scholar
• K Abuabara, J Blue. Providing medical abortion in developing countries: an introductory guidebook. Results of a team residency at the Bellagio Study and Conference Center. 2004; Gynuity Health Projects: New York.
   Google Scholar
• JL Carbonell, L Varela, A Velazco. The use of misoprostol for abortion at less than or equal to 9 weeks' gestation. European Journal of Contraception and Reproductive Health Care. 2(3): 1997; 181–185.
   PubMedGoogle Scholar
• JK Jain, KR Meckstroth, DR Michell Jr. Early pregnancy termination with intravaginally administered sodium chloride solution-moistened misoprostol tablets: historical comparison with mifepristone and oral misoprostol. American Journal of Obstetrics and Gynecology. 181(6): 1999; 1386–1391.
   Web of Science ®Google Scholar
• JL Carbonell, J Rodriguez, S Aragon. Vaginal misoprostol 1000 micrograms for early abortion. Contraception. 63(3): 2001; 131–136.
   Web of Science ®Google Scholar
• JK Jain, B Harwood, KR Meckstroth. Early pregnancy termination with vaginal misoprostol combined with loperamide and acetaminophen prophylaxis. Contraception. 63(4): 2001; 217–221.
   Web of Science ®Google Scholar
• JK Jain, C Dutton, B Harwood. A prospective randomized, double-blinded, placebo-controlled trial comparing mifepristone and vaginal misoprostol to vaginal misoprostol alone for elective termination of pregnancy. Human Reproduction. 17(6): 2002; 1477–1482.
   Web of Science ®Google Scholar
• D Billings. Misoprostol alone for early medical abortion in a Latin American clinic setting. Reproductive Health Matters. 12(24 Suppl): 2004; 57–64.
   Web of Science ®Google Scholar
• J Sherris, A Bingham, MA Burns. Misoprostol use in developing countries: results from a multicountry study. International Journal of Gynecology and Obstetrics. 88(1): 2005; 76–81.
   PubMed Web of Science ®Google Scholar
• AE Pollack, RN Pine. Opening a door to safe abortion: international perspectives on medical abortifacient use. Journal of American Medical Women's Association. 55(3 Suppl): 2000; 186–188.
   PubMedGoogle Scholar
• K Blanchard, S Clark, B Winikoff. Misoprostol for women's health: a review. Obstetrics and Gynecology. 99(2): 2002; 316–332.
   PubMed Web of Science ®Google Scholar
• MM Lafaurie, D Grossman, E Troncoso. Women's perspectives on medical abortion: an exploratory, qualitative study in Mexico, Colombia, Ecuador and Peru. Reproductive Health Matters. 13(26): 2005; 75–83.
   PubMed Web of Science ®Google Scholar
• NM Philip, B Winikoff, K Moore. A consensus regimen for early abortion with misoprostol. International Journal of Gynecology and Obstetrics. 87(3): 2004; 281–283.
   Web of Science ®Google Scholar
• VE Faria. Government policy and fertility regulation: unintended consequences and perverse effects. Brazilian Journal of Population Studies. 1: 1997; 1–29.
   Google Scholar
• JM Belizan, F Althabe, FC Barros. Rates and implications of caesarean sections in Latin America: ecological study. British Medical Journal. 319: 1999; 1397–1400.
   PubMed Web of Science ®Google Scholar
• A Castro. Commentary: increase in caesarean sections may reflect medical control not women's choice. British Medical Journal. 319: 1999; 1401–1402.
   PubMed Web of Science ®Google Scholar
• Silva M. Physicians and abortion: a study of the willingness to provide legal abortion due to rape in Mexico. PhD dissertation (defended 6 September 2005). Tulane University, Department of International Health and Development, New Orleans, LA.
   Google Scholar
• I Torres Escobar. Actitud de los médicos tratantes de los abortos que se presentan en los hospitales del Distrito federal. GIRE: Investigación preparada para Population Council/Ipas. México. 1993
   Google Scholar
• GL Jenkins. Burning bridges: policy, practice, and the destruction of midwifery in rural Costa Rica. Social Science & Medicine. 56(9): 2003; 1893–1909.
   PubMed Web of Science ®Google Scholar
• SE Aguilar, O Ortiz. Preprueba del tríptico informativo: aborto médico temprano con misoprostol. Unpublished report to Ipas. 2004
   Google Scholar
• Consensus Statement: Instructions for use - Abortion induction with misoprostol in pregnancies through nine weeks LMP. Expert meeting on misoprostol. Reproductive Health Technologies Project, Gynuity Health Projects. Washington DC, 28 July 2003.
   Google Scholar
• K Blanchard, T Shochet, K Coyaji. Misoprostol alone for early abortion: an evaluation of seven potential regimens. Contraception. 72(2): 2005; 91–97.
   PubMed Web of Science ®Google Scholar
• H Gould, C Ellertson, G Corona. Knowledge and attitudes about the differences between emergency contraception and medical abortion among middle-class women and men of reproductive age in Mexico City. Contraception. 66(6): 2002; 417–426.
   Web of Science ®Google Scholar
• HL McNaughton, EMH Mitchell, MM Blandon. Should doctors be the judges? Ambiguous policies on legal abortion in Nicaragua. Reproductive Health Matters. 12(24 Suppl): 2004; 18–26.
   Web of Science ®Google Scholar
• FA Althaus. Work in progress: the expansion of access to abortion services in South Africa following legalization. International Family Planning Perspectives. 26(2): 2000; 84–86.
   Google Scholar
• Ipas, IHCAR. Deciding women's lives are worth saving: expanding the role of midlevel providers in safe abortion care. Issues in Abortion Care 7. 2002; Chapel Hill: Ipas.
   Google Scholar
• J Beitz. Increasing access to reproductive health services through pharmacists. Outlook. 21(2): 2004; 1–8.
   Google Scholar
• Lara D, Abuabara K, Grossman D, et al. Pharmacist provision of medical abortifacients in Mexico City. Abstract presented at American Public Health Association Annual Meeting, Washington DC, 8 November 2004.
   Google Scholar